Next generation sequencing for personalized therapy: About a class III BRAF N581K mutation associated to NRAS Q61L mutation in malignant melanoma: Case report.

Croix, Manuel; Levallet, Guénaëlle; Richard, Nicolas; Bracquemart, Claire; Tagmouti, Taha; Dompmartin, Anne; Kottler, Diane; L'Orphelin, Jean Matthieu

Croix, Manuel; Levallet, Guénaëlle; Richard, Nicolas; Bracquemart, Claire; Tagmouti, Taha; Dompmartin, Anne; Kottler, Diane; L'Orphelin, Jean Matthieu.

Afiliação

Croix M; Dermatology Department, Caen University Hospital, Avenue Côte-de-Nacre, 14000 Caen, France.
Levallet G; Caen University, Medicine University, Rue des Rochambelles, 14032 Caen, France.
Richard N; Federative Structure of Cyto-Molecular Oncogenetics (SF-MOCAE), CHU de Caen, F-14000 Caen, France.
Bracquemart C; Department of Pathology, CHU de Caen, F-14000 Caen, France.
Tagmouti T; Normandy University, UNICAEN, CNRS, ISTCT, GIP CYCERON, F-14000 Caen, France.
Dompmartin A; Federative Structure of Cyto-Molecular Oncogenetics (SF-MOCAE), CHU de Caen, F-14000 Caen, France.
Kottler D; Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, EA 7450 Bio-TARGen, Caen, France.
L'Orphelin JM; Federative Structure of Cyto-Molecular Oncogenetics (SF-MOCAE), CHU de Caen, F-14000 Caen, France.

Heliyon ; 9(8): e18420, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37533985

Palavras-chave

BRAF; Melanoma; NRAS; Non V600 mutant; Treatment NGS

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google